Omicron-specific Vaccines Under Development at Moderna and the Pfizer-BioNTech Partnership ... - Latest Tweet by Bloomberg

Omicron-specific vaccines under development at Moderna and the Pfizer-BioNTech partnership will be “little or no better” than currently available boosters, shifting the focus to the next generation of pan-coronavirus shots. https://t.co/3hL31ADEt9— Bloomberg (@business) August 10, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)